Drugs in development for treatment of patients with cancer-related anorexia and cachexia syndrome
Giovanni Mantovani, Clelia Madeddu, Antonio Macciò Department of Medical Oncology, University of Cagliari, Cagliari, Italy Abstract: Cancer-related anorexia and cachexia syndrome (CACS) is a complex multifactorial condition, with loss of lean body mass, chronic inflammation, severe metabo...
Saved in:
Main Authors: | Mantovani G (Author), Madeddu C (Author), Maccio A (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2013-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Drugs in development for treatment of patients with cancer-related anorexia and cachexia syndrome [Retraction]
by: Mantovani G, et al.
Published: (2013) -
A Review of Olanzapine in the Treatment of Cancer Anorexia-Cachexia Syndrome
by: Ivy O. Poon, et al.
Published: (2024) -
IUPHAR ECR review: Cancer-related anorexia-cachexia in cancer patients: Pathophysiology and treatment
by: Iftekhar Hossain Chowdhury, et al.
Published: (2024) -
Anamorelin hydrochloride in the treatment of cancer anorexia–cachexia syndrome: design, development, and potential place in therapy
by: Graf SA, et al.
Published: (2017) -
Cancer anorexia‐cachexia syndrome is characterized by more than one inflammatory pathway
by: Bruno Gagnon, et al.
Published: (2024)